Severity of asthma score predicts clinical outcomes in patients with moderate to severe persistent asthma

Chest

Volumn 141, Issue 1, 2012, Pages 58-65

  Eisner, Mark D ^a   Yegin, Ashley ^a   Trzaskoma, Benjamin ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMALIZUMAB;

ADULT; ARTICLE; ASTHMA; ASTHMA CONTROL TEST; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SEVERITY OF ASTHMA SCORE; STATISTICAL MODEL; TREATMENT OUTCOME; WORK PRODUCTIVITY AND IMPAIRMENT INDEX ASTHMA;

EID: 84855424211     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0020     Document Type: Article

References (29)

1. Trends in Asthma Morbidity and Mortality. American Lung Association. http://www.lungusa.org/finding-cures/our-research/ trend-reports/asthma-trend- report.pdf. Published 2011. Accessed April 2, 2011.
2. Dolan CM, Fraher KE, Bleecker ER, et alTENOR Study Group. Design and baseline characteristics of the epidemiology and natural history of asthma:Outcomes and Treatment Regimens (TENOR) study:a large cohort of patients with severe or diffi cult-to-treat asthma. Ann Allergy Asthma Immunol. 2004;92(1):32-39. (Pubitemid 38113629)
3. Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world Evaluation of Asthma Control and Treatment (REACT):fi ndings from a national Web-based survey. J Allergy Clin Immunol. 2007;119(6):1454-1461. (Pubitemid 46863372)
4. Omachi TA, Iribarren C, Sarkar U, et al. Risk factors for death in adults with severe asthma. Ann Allergy Asthma Immunol. 2008;101(2):130-136.
5. Miller MK, Lee JH, Blanc PD, et al. TENOR Study Group. TENOR risk score predicts healthcare in adults with severe or diffi cult-to-treat asthma. Eur Respir J. 2006;28 (6):1145-1155. (Pubitemid 44883849)
6. National Asthma Education and Prevention Program. Expert Panel Report 3:Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD :US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute;2007.
7. Ng TP. Validity of symptom and clinical measures of asthma severity for primary outpatient assessment of adult asthma. Br J Gen Pract. 2000;50(450):7-12. (Pubitemid 30025995)
8. Sullivan SD, Wenzel SE, Bresnahan BW, et al. TENOR Study Group. Association of control and risk of severe asthmarelated events in severe or diffi cult-to-treat asthma patients. Allergy. 2007;62(6):655-660. (Pubitemid 46763446)
9. Chen H, Gould MK, Blanc PD, et al.; for the TENOR Study Group. Asthma control, severity, and quality of life:quantifying the effect of uncontrolled disease. J Allergy Clin Immunol. 2007;120(2):396-402. (Pubitemid 47103330)
10. Reddel HK, Taylor DR, Bateman ED, et al. American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An offi cial American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations:standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59-99.
11. Lazarus SC, Boushey HA, Fahy JV, et al. Asthma Clinical Research Network for the National Heart, Lung, and Blood Institute. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma:a randomized controlled trial. JAMA. 2001;285(20):2583-2593. (Pubitemid 32479898)
12. Blanc PD, Cisternas M, Smith S, Yelin EH. Asthma, employment status, and disability among adults treated by pulmonary and allergy specialists. Chest. 1996;109(3):688-696. (Pubitemid 26086935)
13. Eisner MD, Katz PP, Yelin EH, Shiboski SC, Blanc PD. Risk factors for hospitalization among adults with asthma:the influence of sociodemographic factors and asthma severity. Respir Res. 2001;2(1):53-60. (Pubitemid 34187906)
14. Eisner MD, Katz PP, Yelin EH, Henke J, Smith S, Blanc PD. Assessment of asthma severity in adults with asthma treated by family practitioners, allergists, and pulmonologists. Med Care. 1998;36(11):1567-1577. (Pubitemid 128456392)
15. Long AA, Fish JE, Rahmaoui A, et al. Baseline characteristics of patients enrolled in EXCELS:a cohort study. Ann Allergy Asthma Immunol. 2009;103(3):212-219.
16. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test:a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59-65. (Pubitemid 38096162)
17. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353-365.
18. Chen H, Blanc PD, Hayden ML, Bleecker ER, Chawla A, Lee JH; TENOR Study Group. Assessing productivity loss and activity impairment in severe or diffi cult-to-treat asthma. Value Health. 2008;11(2):231-239. (Pubitemid 351473606)
19. Blanc PD, Jones M, Besson C, Katz P, Yelin E. Work disability among adults with asthma. Chest. 1993;104(5):1371-1377. (Pubitemid 23327847)
20. Eisner MD, Yelin EH, Katz PP, Lactao G, Iribarren C, Blanc PD. Risk factors for work disability in severe adult asthma. Am J Med. 2006;119(10):884-891. (Pubitemid 44415608)
21. Bloch DA, Moses LE, Michel BA. Statistical approaches to classifi cation. Methods for developing classifi cation and other criteria rules. Arthritis Rheum. 1990;33(8):1137-1144. (Pubitemid 20273300)
22. Breiman L, Friedman JH, Olshen RA, et al. Classifi cation and Regression Trees. Boca Raton, FL :Chapman & Hall/ CRC;1984.
23. Li D, German D, Lulla S, Thomas RG, Wilson SR. Prospective study of hospitalization for asthma. A preliminary risk factor model. Am J Respir Crit Care Med. 1995;151 (3 pt 1):647- 655.
24. Pilote L, Miller DP, Califf RM, Rao JS, Weaver WD, Topol EJ. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction . N Engl J Med. 1996;335(16):1198-1205. (Pubitemid 26339775)
25. Schatz M, Mosen DM, Kosinski M, et al. Validity of the Asthma Control Test completed at home. Am J Manag Care. 2007;13(12):661-667. (Pubitemid 350294567)
26. Schatz M, Kosinski M, Yarlas AS, Hanlon J, Watson ME, Jhingran P. The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol. 2009;124(4):719-723., e1.
27. Schatz M, Sorkness CA, Li JT, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549-556. (Pubitemid 43340217)
28. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves:a nonparametric approach. Biometrics. 1988;44(3):837-845.
29. Eisner MD, Boland M, Tolstykh I, Mendoza G, Iribarren C. Intensive care unit admission for asthma:a marker for severe disease. J Asthma. 2005;42(5):315-323. (Pubitemid 41105701)